Accutane Maker Receives Verdict Reversal
The acne drug, Accutane, manufactured by Roche Holding AG, came on the market in 1982 and has been linked to very serious medical problems such as IBD (inflammatory bowel disease or disorder). IBD is a painful, inflammatory condition of the colon and small intestine. Since 2007, Roche has lost all seven cases against the acne drug and has paid plaintiffs well over $45 million in damages.
Roche recently won a verdict reversal with appellate judges stating “Roche was unduly impeded at this trial from adducing and advocating numerical proofs that could have potentially and reasonably led a jury to reach a different verdict.” The verdict was $10.5 million awarded to Kamie Kendall, a Utah resident who blamed Accutane for her IBD.
Accutane has been Roche’s second biggest-selling drug since it came on the market over twenty-five years ago; an estimated 13 million people have taken the drug. The drug has also been linked to depression and birth defects of babies born to mothers taking the drug.
If you or a loved one has been harmed by a dangerous drug, please contact the pharmaceutical litigation attorneys at Schlichter, Bogard & Denton today to schedule a confidential, no-cost consultation.